Advanced Search


Study ID Status Title Patient Level Data
201402 Completed A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions Study Listed on
201426 Completed PRJ2250: Survey of patient and prescriber understanding of risks associated with TROBALT
201450 Not yet recruiting ENCRUSE ELLIPTA Drug Use Investigation
201474 Completed A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects with Allergic Rhinitis Study Listed on
201514 Active, Not Recruiting Impact of initiating maintenance treatment (MT) promptly post-chronic obstructive pulmonary disease (COPD) exacerbation in a managed care setting
201527 Completed Comparative Randomized, Single dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole from Idiazole 20mg DR tabs (GSK, Egypt)and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a Single Oral Dose Administration of each to Healthy Adults under Fasting Conditions
201528 Completed Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Rabeprazole from Raperazole 20mg DR tabs (GSK, Egypt) and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a single oral dose administration of each to healthy adults under fed conditions
201529 Completed Comparative Randomized, Single Dose, Two-way Crossover, Open-label Study to Determine the Bioequivalence of Cefadroxil from Duricef 1 gm Film Coated Tablets (Smithkline Beecham Egypt, LLC Affiliated Co. to GalaxoSmithKline ) and Biodroxil 1 gm Film Coated tablets (Kahira Pharm &Chem .Ind. Co. for Novartis Pharma ) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions Study Listed on
201539 Active, Not Recruiting A retrospective data collection of the parameters required as per Belgian reimbursement criteria in SLE patients having received belimumab
201657 Completed Meta-analysis of clinical efficacy studies of licensed Rheumatoid Arthritis (RA) treatments
201713 Completed An Open-label, Randomized, Single Dose, Three-way Crossover, Six Sequence Pilot Study to Determine the Relative Bioavailability of Candesartan Cilexetil 16mg From Two Candidate Tablet Formulations of GW615775 Relative to One 16mg Tablet of Reference Candesartan Cilexetil in Healthy Adult Human Subjects Under Fasting Conditions
201718 Active, Not Recruiting WEUSKOP6069: Exploratory Cluster Analysis: Relovair COPD exacerbation studies - which patients benefit most from ICS?
201724 Active, Not Recruiting HO-14-15325 - Cost of Illness Associated with Early Combination Treatment of BPH in the US
201804 Active, Not Recruiting PRJ2335: An Observational Study of the Risk of Acute Pancreatitis in Subjects Exposed to Albiglutide, Other GLP-1 Agonists and DPP-4 Inhibitors Compared to Other Antidiabetic Agents
201805 Active, Not Recruiting PRJ2331: An Observational Study of the Risk of Malignant Neoplasms and Malignant Neoplasms of Special Interest (Thyroid and Pancreatic Cancer) in Subjects Treated with Albiglutide Compared to Those Treated with Other Antidiabetic Agents
201834 Completed A randomized, double-blind, single-dose, placebo controlled, 2-way cross-over study evaluating effect of albiglutide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects
201908 Active, Not Recruiting HO-14-15413 - Evidence Synthesis and Mixed Treatment Comparison of Efficacy of Treatments for the Maintenance of Asthma (annual updates)
201909 Completed An open-label study investigating critical and overall errors following 14 days of treatment with SERETIDE Metered Dose Inhaler (EVOHALER) in adult subjects with controlled asthma currently using the SERETIDE DISKUS Inhaler Study Listed on
201929 Recruiting Efficacy of ropinirole controlled-release on the motor symptoms in advanced Parkinson’s disease patients: A post-hoc analysis of Japanese phase III clinical trial (Study ID: 201929)
201954 Active, Not Recruiting PRJ2379: A retrospective cohort study to assess the utilization of albiglutide among women of child bearing age in the U.S.
201959 Completed A Phase III study for the evaluation of the immunogenicity and reactogenicity of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 season Southern Hemisphere) in adults 18 years of age and above Study Listed on
202012 Completed PRJ2429: Effect of inhaled corticosteroid (ICS) particle size on asthma efficacy and safety outcomes: A systematic literature review and meta-analysis
202115 Completed Can social listening data be used to provide meaningful insights into potential abuse of bupropion?
203821 Completed Summary Document Analysis Plan for the Meta-Analysis and Assessment of Serious Event Outcomes in Patients with Persistent Asthma Receiving Salmeterol in Combination with Fluticasone as ADVAIR
204511 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of ANORO administered in Korean subjects with chronic obstructive pulmonary disease (COPD) in usual practice



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.